VOORHEES, N.J. — Adult glioblastoma is a challenging diagnosis which carries a poor prognosis and appears to be associated with genetic alterations of several critical signaling and tumor suppressor pathways.
While current treatment options are not curative, there is hope for improving outcomes for patients. In order to do this, healthcare professionals must have an understanding of glioblastoma chromosomal risk factors, new radiation therapy techniques, and strategies to overcome obstacles related to blood-brain barrier penetration.
To address the need for current education on adult glioblastoma, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring complimentary educational lectures at medical institutions across the United States. These lectures, which are accredited for physicians, pharmacists, and nurses, are supported by an educational grant from Schering-Plough.
The faculty for these lectures are experts in neurology, neuro-oncology, and radiation oncology from leading medical institutions. The Chairperson is Marc C. Chamberlain, MD, Professor of Neurology & Neurological Surgery and Chief of the Division of Neuro-Oncology at the University of Washington in Seattle, Washington.
Healthcare professionals can visit www.RMEI.com/GBLectures, call toll-free 1-877-499-2323, or email GBLec[email protected] to schedule a lecture at their institution today.
“Robert Michael Educational Institute LLC recognizes that continuing education plays a crucial role in the provision of quality health care and is dedicated to offering professionals meaningful opportunities for lifelong learning,” says President and CEO, Robert M. Colleluori.
RMEI is a medical education company that specializes in independent, certified and non-certified education. The goal of all certified RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.
For other educational opportunities, please visit www.RMEI.com.